소화기내과
김재준 교수
- [전문분야]
- 소화기내과(위암, 치료내시경, 위장질환)
- [전문진료]
- 위장관질환, 위암, 위선종
최선을 다해 최고를 향해서
안녕하세요.
을지대병원 소화기내과에서 근무하고 있는 김재준 입니다.
주 진료분야는 위장관질환, 위암, 위선종입니다.
모든 환자들에게 최고의 진료를 제공하기 위해 최선을 다하겠습니다.
논문
- Inducible nitric oxide synthase expression in gastroduodenal diseases infected with Helicobacter pylori. helicobacter 2001 Mar;6(1):37-43.
Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea. J Antimicrob Chemother. 2001 Apr;47(4):459-61.
Helicobacter pylori impairs DNA mismatch repair in gastric epithelial cells. Gastroenterology 2002 Aug;123(2):542-53.
EMR for early gastric cancer in Korea: a multicenter retrospective study. Gastrointest Endosc 2007 Oct;66(4):693-700.
Healing rate of EMR-induced ulcer in relation to the duration of treatment with omeprazole. Gastrointest Endosc 2004 Aug;60(2):213-7.
Gastric extremely well-differentiated intestinal-type adenocarcinoma: a challenging lesion to achieve complete endoscopic resection. Endoscopy 2012 Oct;44(10):949-52
Surveillance strategy based on the incidence and patterns of recurrence after curative endoscopic submucosal dissection for early gastric cancer. Endoscopy 2015 Sep;47(9):784-93.
Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for Helicobacter pylori Infection: A Nationwide Randomized Trial in Korea. Gut Liver 2019 Sep 15;13(5):531-540.
Screening for Early Gastric Cancer Using a Noninvasive Urine Metabolomics Approach. Cancers (Basel) 2020 Oct 9;12(10):2904.
Risk of Second Primary Malignancies among Patients with Early Gastric Cancer Exposed to Recurrent Computed Tomography Scans. Cancers (Basel) 2021 Mar 7;13(5):1144.
A preoperative risk prediction model for high malignancy potential gastrointestinal stromal tumors of the stomach. Surg Endosc 2022 Mar;36(3):2129-2137.
Helicobacter Pylori Infection Is Associated with Neurodegeneration in Cognitively Normal Men. J Alzheimers Dis 2021;82(4):1591-1599.
Culture-based susceptibility-guided tailored versus empirical concomitant therapy as first-line Helicobacter pylori treatment: A randomized clinical trial. United European Gastroenterol J 2024 Sep;12(7):941-950.
